Furthermore, Western blotting with freshly collected protein samples from eight IDH-wildtype gliomas showed that YTHDF2 protein levels were elevated in WHO grade IV tumors compared with WHO grade III tumors (Fig. 1K). This evidence concerns the gene YTHDF2 and central nervous system cancer.